Everence Capital Management Inc. Invests $173,000 in Vitamin Shoppe Inc (VSI)

Everence Capital Management Inc. acquired a new position in shares of Vitamin Shoppe Inc (NYSE:VSI) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 24,550 shares of the specialty retailer’s stock, valued at approximately $173,000.

Other hedge funds have also bought and sold shares of the company. AQR Capital Management LLC purchased a new stake in shares of Vitamin Shoppe during the 3rd quarter worth approximately $380,000. Vanguard Group Inc. raised its holdings in shares of Vitamin Shoppe by 11.3% during the 3rd quarter. Vanguard Group Inc. now owns 1,338,743 shares of the specialty retailer’s stock worth $13,387,000 after acquiring an additional 136,203 shares in the last quarter. Vanguard Group Inc raised its holdings in shares of Vitamin Shoppe by 11.3% during the 3rd quarter. Vanguard Group Inc now owns 1,338,743 shares of the specialty retailer’s stock worth $13,387,000 after acquiring an additional 136,203 shares in the last quarter. Quantamental Technologies LLC purchased a new stake in shares of Vitamin Shoppe during the 4th quarter worth approximately $39,000. Finally, Crossmark Global Holdings Inc. raised its holdings in shares of Vitamin Shoppe by 15.5% during the 4th quarter. Crossmark Global Holdings Inc. now owns 41,810 shares of the specialty retailer’s stock worth $198,000 after acquiring an additional 5,600 shares in the last quarter. Institutional investors and hedge funds own 88.21% of the company’s stock.

VSI has been the topic of several recent research reports. ValuEngine cut Vitamin Shoppe from a “buy” rating to a “hold” rating in a report on Tuesday, January 22nd. Zacks Investment Research cut Vitamin Shoppe from a “strong-buy” rating to a “hold” rating in a report on Wednesday, May 1st.



Shares of VSI opened at $4.41 on Wednesday. The company has a market cap of $108.21 million, a PE ratio of 16.96 and a beta of 1.35. Vitamin Shoppe Inc has a 1 year low of $4.27 and a 1 year high of $13.95. The company has a debt-to-equity ratio of 2.36, a quick ratio of 0.16 and a current ratio of 1.14.

Vitamin Shoppe (NYSE:VSI) last issued its quarterly earnings data on Wednesday, May 8th. The specialty retailer reported $0.21 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.24 by ($0.03). The firm had revenue of $283.33 million for the quarter. Vitamin Shoppe had a return on equity of 4.64% and a net margin of 0.33%. As a group, equities analysts forecast that Vitamin Shoppe Inc will post 0.55 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This story was first published by Dakota Financial News and is the sole property of of Dakota Financial News. If you are viewing this story on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The original version of this story can be viewed at https://dakotafinancialnews.com/2019/05/22/everence-capital-management-inc-invests-173000-in-vitamin-shoppe-inc-vsi.html.

Vitamin Shoppe Profile

Vitamin Shoppe, Inc, through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products.

Recommended Story: How to find the components of the quick ratio

Want to see what other hedge funds are holding VSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vitamin Shoppe Inc (NYSE:VSI).

Institutional Ownership by Quarter for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.